Rakuten Medical Announces Phase 3 Trial Progress for ASP-1929 Photoimmunotherapy at ASCO 2025

Rakuten Medical announced that it will present a Trial in Progress poster at the 2025 ASCO Annual Meeting, showcasing its global Phase 3 clinical tria...
Home/KnloSights/Clinical Trial Updates/Rakuten Medical Announces Phase 3 Trial Progress for ASP-1929 Photoimmunotherapy at ASCO 2025